Recombinant Human CXCL3 protein (mFc Tag)
种属
Human
纯度
>90 %, SDS-PAGE
标签
mFc Tag
生物活性
未测试
验证数据展示
产品信息
| 纯度 | >90 %, SDS-PAGE |
| 内毒素 | <0.1 EU/μg protein, LAL method |
| 生物活性 |
Not tested |
| 来源 | HEK293-derived Human CXCL3 protein Ala35-Asn107 (Accession# O88792) with a mouse IgG Fc tag at the C-terminus. |
| 基因ID | 2921 |
| 蛋白编号 | P19876 |
| 预测分子量 | 34.5 kDa |
| SDS-PAGE | 34-40 kDa, reducing (R) conditions |
| 组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
| 复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
| 储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
CXCL3, also known as GRO-gamma, belongs to the CXC family of chemokines. CXCL3 is highly expressed in a variety of malignant tumors, including prostate cancer, breast cancer, and endometrial cancer. At the same time, CXCL3 has also been found to be widely present in inflammatory tissues and liver damage tissues.CXCL3 not only participates in the occurrence of tumors but also plays an important role in tumor progression. CXCL3 plays a key role in angiogenesis, tumorigenesis, and cell invasion and migration.
参考文献:
1.Weng J. et al. (2021) J Oral Pathol Med. 50(9):902-910. 2.Cui C. et al. (2022) J Immunol Res. 2022:1336509. 3.Cheng Y. et al. (2023) BMC Cancer. 23(1):1162.
